The relationship between Vimentin and the E3 ubiquitin ligase SYVN1 in breast cancer has previously been reported24 and our findings confirm that circARPC1B inhibits Vimentin degradation by blocking Vimentin‐SYVN1 binding. Here, SYVN1 is linked to breast carcinoma.